Rockwell Medical, Inc.
RMTI
$0.831
-$0.017-2.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.52M | -756.00K | 1.66M | 343.00K | -1.73M |
| Total Depreciation and Amortization | 539.00K | 543.00K | 543.00K | 549.00K | 545.00K |
| Total Amortization of Deferred Charges | 88.00K | 89.00K | 88.00K | 30.00K | 219.00K |
| Total Other Non-Cash Items | 1.14M | 984.00K | 1.14M | 709.00K | 770.00K |
| Change in Net Operating Assets | -3.74M | 5.00K | 840.00K | -189.00K | -2.18M |
| Cash from Operations | -3.49M | 865.00K | 4.28M | 1.44M | -2.38M |
| Capital Expenditure | -63.00K | -395.00K | -191.00K | -286.00K | -139.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.00K | 63.00K | -5.92M | 2.00M | -- |
| Cash from Investing | -1.00K | -332.00K | -6.11M | 1.72M | -139.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -347.00K | -343.00K | -341.00K | -138.00K | -382.00K |
| Issuance of Common Stock | -- | 3.79M | 3.63M | 2.20M | 560.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -436.00K | -653.00K | -976.00K | -- | -- |
| Cash from Financing | -783.00K | 2.79M | 2.31M | 2.07M | 178.00K |
| Foreign Exchange rate Adjustments | -- | -1.00K | -1.00K | -3.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.27M | 3.32M | 475.00K | 5.22M | -2.34M |